191 related articles for article (PubMed ID: 12595358)
1. Anti-Glaxo campaign heats up in United States.
Moynihan R
BMJ; 2003 Feb; 326(7386):413. PubMed ID: 12595358
[No Abstract] [Full Text] [Related]
2. Seizures of Canadian drugs rise as Congress, Customs spar.
Carreyrou J
Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
[No Abstract] [Full Text] [Related]
3. US buyers of drugs from Canadian pharmacies face prosecution.
Spurgeon D
BMJ; 2003 Mar; 326(7390):618. PubMed ID: 12649223
[No Abstract] [Full Text] [Related]
4. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
Tetteh E
Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
[No Abstract] [Full Text] [Related]
5. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
Buckely M
Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
[No Abstract] [Full Text] [Related]
6. Economic and policy implications of reimportation: a Canadian perspective.
Ward C
Manag Care; 2004 Mar; 13(3 Suppl):17-20. PubMed ID: 15074165
[No Abstract] [Full Text] [Related]
7. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
8. Global "hold-em".
Cassidy BS
Geriatr Nurs; 2006; 27(1):21-3. PubMed ID: 16483897
[No Abstract] [Full Text] [Related]
9. [Essential drugs available to all].
Bol Oficina Sanit Panam; 1992; 113(5-6):539-43. PubMed ID: 1296697
[No Abstract] [Full Text] [Related]
10. Prescription drug prices in Canada.
Gross D
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
[No Abstract] [Full Text] [Related]
11. Drug assistance from drug makers.
Hanson K
State Legis; 2003 Jun; 29(6):22-4. PubMed ID: 12785350
[TBL] [Abstract][Full Text] [Related]
12. Increased direct-to-consumer advertising driving pharmaceutical costs, trends.
Fine A
Exec Solut Healthc Manag; 1999 Jan; 2(1):2-3. PubMed ID: 10345986
[No Abstract] [Full Text] [Related]
13. The cost and availability of prescription drugs--what can we do in Massachusetts?
Carpenter NW; Kedikoglou S
Issue Brief (Mass Health Policy Forum); 1999 May; (4):1-41. PubMed ID: 12769091
[No Abstract] [Full Text] [Related]
14. US drug shortages are set to reach record high in 2011, report says.
Tanne JH
BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
[No Abstract] [Full Text] [Related]
15. Canada moves to shut Rx pipeline.
Boehm C
Revolution (Oakl); 2005; 6(4):4-5. PubMed ID: 16187566
[No Abstract] [Full Text] [Related]
16. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
17. India: access to affordable drugs and the right to health.
Grover A; Citro B
Lancet; 2011 Mar; 377(9770):976-7. PubMed ID: 21227487
[No Abstract] [Full Text] [Related]
18. The Health Impact Fund: incentives for improving access to medicines.
Banerjee A; Hollis A; Pogge T
Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894
[No Abstract] [Full Text] [Related]
19. Where does drug importation stand now?
Guglielmo WJ
Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
[No Abstract] [Full Text] [Related]
20. Pharmacy benefit managers and their obligations during serious prescription drug shortages.
Teagarden JR; Epstein RS
Clin Pharmacol Ther; 2013 Feb; 93(2):143-5. PubMed ID: 23337523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
